AlloDerm and Strattice in Breast Reconstruction
- 1 June 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Plastic and Reconstructive Surgery
- Vol. 129 (6), 1223-1233
- https://doi.org/10.1097/prs.0b013e31824ec429
Abstract
Acellular dermal matrices are increasingly used to reinforce the lower pole of the breast during tissue expander/implant breast reconstruction. Although a low complication rate and good aesthetic outcome have been reported, meticulous technique is important for success. This retrospective study compared the clinical course and postoperative outcome of women who underwent breast reconstruction using AlloDerm or Strattice in the authors' practice and highlights key technical considerations that are important for optimizing outcomes. Patient records were reviewed for demographic data, operative parameters (length and volume of drainage), and type and frequency of postoperative complications, which were compared between the AlloDerm and Strattice groups. Biopsy specimens of acellular dermal matrices were taken for histologic analyses. Ninety-six patients (126 reconstructions) received AlloDerm, and 90 (144 reconstructions) received Strattice. Total complications were significantly higher with AlloDerm (21.4 percent versus 6.3 percent; p = 0.0003) and were driven by a significantly higher seroma rate (12.7 percent versus 1.4 percent; p = 0.0003). All other complications were similar between the groups. The capsular contracture rate (grade 1 or 2) was 2.4 percent with AlloDerm and 2.8 percent with Strattice, indicating that both may play a role in capsule formation. This was supported by histologic analyses indicating an absence of synovia-like metaplasia at the acellular dermal matrix/tissue expander interface. : Complications in this series were of low severity, which, together with consistent clinical outcomes seen in the authors' practice, justifies the cost associated with the use of acellular dermal matrices in breast reconstruction. Therapeutic: III.Keywords
This publication has 21 references indexed in Scilit:
- An 8-Year Experience of Direct-to-Implant Immediate Breast Reconstruction Using Human Acellular Dermal Matrix (AlloDerm)Plastic and Reconstructive Surgery, 2011
- Acellular Cadaveric Dermis Decreases the Inflammatory Response in Capsule Formation in Reconstructive Breast SurgeryPlastic and Reconstructive Surgery, 2010
- Acellular Human Dermis Implantation in 153 Immediate Two-Stage Tissue Expander Breast Reconstructions: Determining the Incidence and Significant Predictors of ComplicationsPlastic and Reconstructive Surgery, 2010
- The Effect of Acellular Dermal Matrix Use on Complication Rates in Tissue Expander/Implant Breast ReconstructionAnnals of Plastic Surgery, 2010
- Implant-Based Breast Reconstruction Using Acellular Dermal Matrix and the Risk of Postoperative ComplicationsPlastic and Reconstructive Surgery, 2010
- Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site AntisepsisThe New England Journal of Medicine, 2010
- AlloDerm Performance in the Setting of Prosthetic Breast Surgery, Infection, and IrradiationPlastic and Reconstructive Surgery, 2009
- Expander/Implant Reconstruction with AlloDerm: Recent ExperiencePlastic and Reconstructive Surgery, 2009
- The Influence of AlloDerm on Expander Dynamics and Complications in the Setting of Immediate Tissue Expander/Implant ReconstructionAnnals of Plastic Surgery, 2008
- Mammary Reconstruction Using Tissue Expander and Partial Detachment of the Pectoralis Major Muscle to Expand the Lower Breast QuadrantsAnnals of Plastic Surgery, 2004